AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Euclide M 30 OD Tablet ER

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Gliclazide (30mg) + Metformin (500mg)

Overview Euclide M 30 OD Tablet ER

Diabetol Duo 30mg Extended-Release tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Diabetol Duo 30mg should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is vital, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of complications including nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are crucial for diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Carry a rapid-acting glucose source (e.g., sugary snacks or juice) to counter hypoglycemia and maintain regular mealtimes. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional side effects may include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Uses of Euclide M 30 OD Tablet ER

Adult-onset diabetes

Major Benefits of Euclide M 30 OD Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Euclide M 30 OD Tablet ER with a meal.

Common Side effects of Euclide M 30 OD Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Euclide M 30 OD Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Euclide M 30 OD Tablet ER should be administered with a meal.

How Euclide M 30 OD Tablet ER works:

Gliclazide and metformin are combined in the extended-release Euclide M 30 OD tablet, a medication for managing diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Euclide M 30 OD Tablet ER is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Euclide M 30 OD Tablet ER is contraindicated during pregnancy due to confirmed risk to the fetus. In exceptional life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Euclide M 30 OD tablets are likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Euclide M 30 OD Tablet ER cautiously, potentially requiring dosage modification. Physician consultation is recommended. Euclide M 30 OD Tablet ER is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Euclide M 30 OD Tablet ER cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose of Euclide M 30 OD Tablet ER is typical; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Euclide M 30 OD Tablet ER :

Should you forget a dose of Euclide M 30 OD Tablet ER, take it immediately if you remember. However, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Euclide M 30 OD Tablet ER

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Euclide M 30 OD Tablet ER

Euclide M 30 OD Tablet ER combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication enhances glycemic control when used with a healthy diet and regular physical activity. Gliclazide functions by stimulating pancreatic insulin secretion, while metformin reduces hepatic glucose output and improves insulin responsiveness. This dual-agent therapy is unsuitable for type 1 diabetes.
Taking Euclide M 30 OD Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal discomfort, loose stools, headache, and upper respiratory infections. Rare but serious adverse events, including lactic acidosis, are also possible. Prolonged treatment might result in vitamin B12 deficiency.
Indeed, Euclide M 30 OD Tablet ER can induce hypoglycemia. Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of unease or tremor. This adverse effect is amplified by skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential, though uncommon, adverse effect of Euclide M 30 OD Tablet ER (metformin). This complication, also termed MALA (Metformin-associated lactic acidosis), constitutes a medical emergency. To minimize risk, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, and those consuming significant quantities of alcohol. Warning signs may encompass muscular discomfort or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal pain, and bradycardia. Should any of these symptoms arise, discontinue Euclide M 30 OD Tablet ER intake and seek immediate medical attention.
Prolonged use of Euclide M 30 OD Tablet ER can indeed lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Left unaddressed, this deficiency may result in anemia, neurological issues, including tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and impaired balance. To mitigate these risks, supplemental vitamin B12 intake, at minimum annually, has been proposed by some experts.
Patients with a documented hypersensitivity to any constituent or inactive ingredient within Euclide M 30 OD Tablet ER should not receive this medication. Furthermore, its administration is contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Euclide M 30 OD Tablet ER and alcohol is unsafe. This combination may dangerously reduce blood sugar, increasing the risk of lactic acidosis.
Euclide M 30 OD Tablet ER combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used with a healthy diet and regular physical activity. Gliclazide stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin sensitivity. This formulation is unsuitable for treating type 1 diabetes.
Euclide M 30 OD Tablet ER administration is linked to several frequently reported adverse reactions. These include hypoglycemia, taste disturbances, nausea, abdominal discomfort, diarrhea, cephalalgia, and upper respiratory infections. While uncommon, serious adverse events such as lactic acidosis may occur. Prolonged therapy may result in vitamin B12 deficiency.
Indeed, Euclide M 30 OD Tablet ER can induce hypoglycemia. Manifestations of low blood sugar include nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Always carry readily available glucose sources such as glucose tablets, honey, or fruit juice.
Euclide M 30 OD Tablet ER use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an infrequent adverse reaction to metformin. Risk is heightened in individuals with pre-existing kidney impairment, the elderly, and those consuming substantial alcohol. Symptoms may manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, vomiting, abdominal discomfort, or bradycardia. If these symptoms appear, discontinue Euclide M 30 OD Tablet ER and seek immediate medical attention.
Prolonged use of Euclide M 30 OD Tablet ER can indeed lead to vitamin B12 deficiency. This is because the medication hinders the stomach's absorption of vitamin B12. Left unaddressed, this deficiency may result in anemia, neurological complications such as tingling and numbness in the extremities, weakness, urinary dysfunction, cognitive changes, and impaired balance. To mitigate these risks, supplemental vitamin B12 intake, at least annually, has been proposed by some investigators.
Patients with hypersensitivity to any ingredient or excipient in Euclide M 30 OD Tablet ER should not use this medication. Its use is contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Euclide M 30 OD Tablet ER and alcohol is unsafe. This combination can dangerously reduce blood sugar (causing hypoglycemia) and heighten the risk of lactic acidosis.
Euclide M 30 OD Tablet ER
80
MRP 98
17% off